Clinical Trial Results:
A randomised, double-blind, parallel group study evaluating the efficacy and safety of co administration of triple combinations of olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide compared with the corresponding olmesartan- amlodipine combination in subjects with hypertension
Summary
|
|
EudraCT number |
2008-003534-25 |
Trial protocol |
LV DE NL ES BE CZ DK BG SK IT |
Global completion date |
12 Jan 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
25 May 2016
|
First version publication date |
25 May 2016
|
Other versions |
|
Summary report(s) |
Report Synopsis CS8635-A-E302 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.